Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis Patients”

1,065 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,065 results

Not applicableNot Yet RecruitingNCT06802848
What this trial is testing

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Who this might be right for
Plaque PsoriasisPsoriatic ArthritisScalp Psoriasis+3 more
Chongqing Genrix Biopharmaceutical Co., Ltd 1,000
Not applicableStudy completedNCT01090063
What this trial is testing

Efficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar Psoriasis

Who this might be right for
Moderate to Severe Palmar Plantar Psoriasis
Tufts Medical Center 26
Early research (Phase 1)Study completedNCT07051538
What this trial is testing

A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Plaque Psoriasis
Guangdong Hengrui Pharmaceutical Co., Ltd 64
Large-scale testing (Phase 3)Study completedNCT01891864
What this trial is testing

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

Who this might be right for
Chronic Stable Plaque Psoriasis
Sandoz 531
Testing effectiveness (Phase 2)Study completedNCT00820950
What this trial is testing

Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 29
Not applicableStudy completedNCT04922840
What this trial is testing

Improved Cardiovascular Health for Patients With Inflammatory Joint Diseases

Who this might be right for
SpondyloarthritisRheumatoid ArthritisPsoriatic Arthritis
Diakonhjemmet Hospital 60
Large-scale testing (Phase 3)Study completedNCT02513550
What this trial is testing

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 1,257
Testing effectiveness (Phase 2)Study completedNCT03230292
What this trial is testing

Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
UCB Biopharma SRL 43
Testing effectiveness (Phase 2)Study completedNCT03069144
What this trial is testing

Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
PsoriasisPsoriasis Vulgaris
Haus Bioceuticals 28
Testing effectiveness (Phase 2)Study completedNCT00585650
What this trial is testing

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

Who this might be right for
Psoriasis
University of California, Irvine 20
Not applicableUnknownNCT03152396
What this trial is testing

Pharmacist CVD Intervention for Patients With Inflammatory Arthritis

Who this might be right for
Inflammatory ArthritisCardiovascular Risk FactorRheumatoid Arthritis+2 more
Epidemiology Coordinating and Research Centre, Canada 100
Not applicableStudy completedNCT04380597
What this trial is testing

Observational Study in Patients With Nail Psoriasis Treated With Enstilar® to Assess the Severity Change and the Quality of Life

Who this might be right for
Nail Psoriasis
Angeles Florez 10
Not applicableStudy completedNCT05650060
What this trial is testing

Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 163
Not applicableStudy completedNCT02361385
What this trial is testing

PBR28 PET and Inflammatory Arthritis

Who this might be right for
Rheumatoid ArthritisPsoriatic Arthritis
University of Oxford 22
Not applicableStudy completedNCT00830817
What this trial is testing

Double-Blind Study of Topical WBI-1001 Cream on Patients With Psoriasis

Who this might be right for
Psoriasis
Welichem Biotech Inc. 36
Not applicableStudy completedNCT02028169
What this trial is testing

To Observe the Impacts of Anti-Tumor Necrosis Factor (TNF) Effectiveness on Improvement in Work Place and Household Productivity for Patients With Psoriatic Arthritis (PsA)

Who this might be right for
Psoriatic ArthritisWork Productivity
AbbVie 120
Not applicableActive Not RecruitingNCT06247319
What this trial is testing

Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece

Who this might be right for
Moderate Plaque PsoriasisModerate PsoriasisPsoriasis
AbbVie 250
Large-scale testing (Phase 3)Study completedNCT01194219
What this trial is testing

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 844
Not applicableNot Yet RecruitingNCT07648836
What this trial is testing

Evaluation of Serum IL-41 Level in Patients With Ankylosing Spondylitis and Psoriatic Arthritis

Who this might be right for
Ankylosing SpondylitisPsoriasis
Assiut University 90
Not applicableStudy completedNCT04428411
What this trial is testing

Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

Who this might be right for
Plaque Psoriasis
Pfizer 486
Next Page